Cancer prevalence in a health insurance organization in Colombia, 2013

被引:4
作者
Alarcon, Blanca [1 ]
Guarin, Natalia [1 ]
Munoz-Galindo, Ivan [1 ]
Diaz, Jorge [2 ]
Arevalo, Helbert [1 ]
机构
[1] Salud Total EPS, Gerencia Nacl Riesgos Salud, Vicepresidencia Tecn & Salud, Bogota, Colombia
[2] Univ Nacl Colombia, Fac Ciencias, Dept Farm, Bogota, Colombia
来源
REVISTA COLOMBIANA DE CANCEROLOGIA | 2015年 / 19卷 / 04期
关键词
Neoplasms; Prevalence; Health insurance; Risk management; Epidemiology; Observational study;
D O I
10.1016/j.rccan.2015.07.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Cancer is one of the leading causes of non-violent death in the world. An estimated eleven million new cases occur worldwide every year, of which 80% occurred in developing countries. Objective: To determine the prevalence of cancer in a population affiliated to a health care insurance organization in Colombia. Materials and Methods: A descriptive cross-sectional study was conducted on a cohort of 11,500 patients with cancer affiliated to a health care organization. The patients were identified from the information systems of the company, during the years 2010-2013. Data were analysed using frequencies, rates, and prevalence ratio. Results: The overall prevalence of cancer was 543 per 100,000 members. The largest proportion of cases (67%) occurred in patients older than 50 years. The cities with the highest prevalence were Manizales, Cali, Pereira and Neiva. The most prevalent cancer types were breast, other solid tumours, prostate, skin, and thyroid. The prevalence of childhood cancer was 65 per 100,000 members under 18 years. Acute lymphoid leukaemia, malignant brain tumours, and lymphomas were the most common malignancies in children. Conclusions: This is the first study of the prevalence of cancer in an insured population in Colombia, becoming a tool for planning services, provide screening strategies, auditing and evaluation of results in the context of health insurance and risk management. (C) 2015 Institut Nacional de Cancerologia. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:210 / 221
页数:12
相关论文
共 26 条
  • [1] Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination
    Armstrong, K
    Weber, B
    FitzGerald, G
    Hershey, JC
    Pauly, MV
    Lemaire, J
    Subramanian, K
    Asch, DA
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 120A (03): : 359 - 364
  • [2] Asociacion Probienestar de la Familia Colombiana (Profamilia), 2013, SER EST PROF ENDS 19
  • [3] Centro para el Control y la Prevencion de Enfermedades [Internet]. Atlanta: CDC, 2015, EST GLOB CANC
  • [4] Departamento Administrativo Nacional de Estadistica (DANE). [Internet]. Bogota: DANE, 2006, IND MORT 1985 2015
  • [5] Donoso S Enrique, 2006, Rev. chil. obstet. ginecol., V71, P10
  • [6] Bravo LE, 2013, COLOMB MEDICA, V44, P155
  • [7] Ferlay J, 2013, GLOBOCAN 2012 V1 0 C
  • [8] Gomez-Arias RD, 2008, REV FAC NAC SALUD PA, V26, P313
  • [9] Holland WW, 1991, COMMISSION EUROPEAN, V6, P9
  • [10] Instituto Nacional del Cancer de Estados Unidos. [Internet]. INS de los EE.UU, 2014, INS DE LOS EE UU